Diabetes does not alter mortality or hemostatic and inflammatory responses in patients with severe sepsis

Critical Care Medicine

Volumn 38, Issue 2, 2010, Pages 539-545

  Stegenga, Michiel E ^a   Vincent, Jean Louis ^b   Vail, George M ^c   Xie, Jin ^c   Haney, Douglas J ^c   Williams, Mark D ^c   Bernard, Gordon R ^d   Van Der Poll, Tom ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ERASME HOSPITAL   (Belgium)

^c ELI LILLY AND COMPANY   (United States)

^d VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Admission hyperglycemia; Coagulation; Diabetes; Inflammation; Mortality; Severe sepsis

Indexed keywords

GLUCOSE;

ADULT; ANTICOAGULATION; ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FIBRINOLYSIS; GLUCOSE BLOOD LEVEL; HEMOSTASIS; HUMAN; HYPERGLYCEMIA; INFLAMMATION; INTENSIVE CARE; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RISK FACTOR; SEPSIS;

EID: 74949113093     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e3181c02726     Document Type: Article

References (34)

1. Shah BR, Hux JE: Quantifying the risk of infectious diseases for people with diabetes. Diabetes Care 2003; 26:510-513
2. Laupland KB, Gregson DB, Zygun DA, et al: Severe bloodstream infections: A population-based assessment. Crit Care Med 2004; 32: 992-997
3. Martin GS, Mannino DM, Eaton S, et al: The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003; 348:1546-1554
4. Levi M, van der Poll T, Buller HR: Bidirectional relation between inflammation and coagulation. Circulation 2004; 109:2698-2704
5. Annane D, Bellissant E, Cavaillon JM: Septic shock. Lancet 2005; 365:63-78
6. Wierusz-Wysocka B, Wysocki H, Wykretow-icz A, et al: The influence of increasing glucose concentrations on selected functions of polymorphonuclear neutrophils. Acta Diabe-tol Lat 1988; 25:283-288
7. Alexiewicz JM, Kumar D, Smogorzewski M, et al: Polymorphonuclear leukocytes in non-insulin-dependent diabetes mellitus: Abnormalities in metabolism and function. Ann Intern Med 1995; 123:919-924
8. Marhoffer W, Stein M, Maeser E, et al: Impairment of polymorphonuclear leukocyte function and metabolic control of diabetes. Diabetes Care 1992; 15:256-260
9. Mooradian AD, Reed RL, Meredith KE, et al: Serum levels of tumor necrosis factor and IL-1 alpha and IL-1 beta in diabetic patients. Diabetes Care 1991; 14:63-65
10. Kado S, Nagase T, Nagata N: Circulating levels of interleukin-6, its soluble receptor and interleukin-6/interleukin-6 receptor complexes in patients with type 2 diabetes melli-tus. Acta Diabetol 1999; 36:67-72
11. Pickup JC, Chusney GD, Thomas SM, et al: Plasma interleukin-6, tumour necrosis factor alpha and blood cytokine production in type 2 diabetes. Life Sci 2000; 67:291-300
12. Yu WK, Li WQ, Li N, et al: Influence of acute hyperglycemia in human sepsis on inflammatory cytokine and counterregulatory hormone concentrations. World J Gastroenterol 2003; 9:1824-1827
13. Carr ME: Diabetes mellitus: a hypercoagula-ble state. J Diabetes Complications 2001; 15: 44-54
14. Stegenga ME, van der Crabben SN, Levi M, et al: Hyperglycemia stimulates coagulation, whereas hyperinsulinemia impairs fibrinoly-sis in healthy humans. Diabetes 2006; 55: 1807-1812
15. Krogh-Madsen R, Moller K, Dela F, et al: Effect of hyperglycemia and hyperinsulin-emia on the response of IL-6, TNF-alpha, and FFAs to low-dose endotoxemia in humans. Am J Physiol Endocrinol Metab 2004; 286: E766-E772
16. Soop M, Duxbury H, Agwunobi AO, et al: Euglycemic hyperinsulinemia augments the cytokine and endocrine responses to endo-toxin in humans. Am J Physiol Endocrinol Metab 2002; 282:E1276-E1285
17. Bernard GR, Vincent JL, Laterre PF, et al: Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001; 344:699-709
18. Kinasewitz GT, Yan SB, Basson B, et al: Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative microorganism [ISRCTN74215569]. Crit Care 2004; 8:R82-R90
19. Dhainaut JF, Yan SB, Margolis BD, et al: Drotrecogin alfa (activated) (recombinant human activated protein C) reduces host co-agulopathy response in patients with severe sepsis. Thromb Haemost 2003; 90:642-653
20. Hastie TJ, Tibshirani RJ: Generalized Additive Models. London, Chapman and Hall, 1990, p. 352
21. Dhainaut JF, Shorr AF, Macias WL, et al: Dynamic evolution of coagulopathy in the first day of severe sepsis: Relationship with mortality and organ failure. Crit Care Med 2005; 33:341-348
22. Rao AK, Chouhan V, Chen X, et al: Activation of the tissue factor pathway of blood coagulation during prolonged hyperglycemia in young healthy men. Diabetes 1999; 48: 1156-1161
23. Ceriello A, Giacomello R, Stel G, et al: Hy-perglycemia-induced thrombin formation in diabetes. The possible role of oxidative stress. Diabetes 1995; 44:924-928
24. Lopez Y, Paloma MJ, Rifon J, et al: Measurement of prethrombotic markers in the assessment of acquired hypercoagulable states. Thromb Res 1999; 93:71-78
25. Carmassi F, Morale M, Puccetti R, et al: Coagulation and fibrinolytic system impairment in insulin dependent diabetes mellitus. Thromb Res 1992; 67:643-654
26. Mavrommatis AC, Theodoridis T, Orfanidou A, et al: Coagulation system and platelets are fully activated in uncomplicated sepsis. Crit Care Med 2000; 28:451-457
27. Mavrommatis AC, Theodoridis T, Economou M, et al: Activation of the fibrinolytic system and utilization of the coagulation inhibitors in sepsis: comparison with severe sepsis and septic shock. Intensive Care Med 2001; 27: 1853-1859
28. Umpierrez GE, Isaacs SD, Bazargan N, et al: Hyperglycemia: An independent marker of in-hospital mortality in patients with undi-agnosed diabetes. J Clin Endocrinol Metab 2002; 87:978-982
29. Capes SE, Hunt D, Malmberg K, et al: Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: A systematic overview. Lancet 2000; 355:773-778
30. Capes SE, Hunt D, Malmberg K, et al: Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: A systematic overview. Stroke 2001; 32:2426-2432
31. Cohen G, Riahi Y, Alpert E, et al: The roles of hyperglycaemia and oxidative stress in the rise and collapse of the natural protective mechanism against vascular endothelial cell dysfunction in diabetes. Arch Physiol Bio-chem 2007; 113:259-267
32. Van den Berghe G, Wilmer A, Milants I, et al: Intensive insulin therapy in mixed medical/surgical intensive care units: Benefit versus harm. Diabetes 2006; 55:3151-3159
33. Brunkhorst FM, Engel C, Bloos F, et al: Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008; 358:125-139
34. Devos P, Preiser J, Mélot C: Impact of tight glucose control by intensive insulin therapy on ICU mortality and the rate of hypoglycae-mia: Final results of the GLUCONTROL study. Intensive Care Med 2007; 33:S189